PER 2.86% 7.2¢ percheron therapeutics limited

Teva has had Copaxone for a very long time it wasn't "under...

  1. 35,729 Posts.
    lightbulb Created with Sketch. 554
    Teva has had Copaxone for a very long time it wasn't "under trial" it was their oral drug under trial. Copaxone's patent is out but it's still the best selling and most utilised drug - just 3 amino acids really. Tevas talked about it a fair bit I haven't looked lately but CEO had plans on company direction after patents folded pushing into neurodegenerative disorders from memory.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $64.91M
Open High Low Value Volume
7.4¢ 7.4¢ 7.0¢ $44.32K 616.8K

Buyers (Bids)

No. Vol. Price($)
1 4250 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 49809 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.